sb 239063 has been researched along with Lung Injury, Acute in 2 studies
SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, G | 1 |
Zhang, Y | 1 |
Liu, X | 1 |
Fang, Q | 1 |
Wang, Z | 1 |
Fu, L | 1 |
Liu, Z | 1 |
Wang, Y | 1 |
Zhao, Y | 1 |
Li, X | 1 |
Liang, G | 1 |
Xiong, LL | 1 |
Tan, Y | 1 |
Ma, HY | 1 |
Dai, P | 1 |
Qin, YX | 1 |
Yang, RA | 1 |
Xu, YY | 1 |
Deng, Z | 1 |
Zhao, W | 1 |
Xia, QJ | 1 |
Wang, TH | 1 |
Zhang, YH | 1 |
2 other studies available for sb 239063 and Lung Injury, Acute
Article | Year |
---|---|
Discovery of a New Inhibitor of Myeloid Differentiation 2 from Cinnamamide Derivatives with Anti-Inflammatory Activity in Sepsis and Acute Lung Injury.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Cinnamates; Cyto | 2016 |
Administration of SB239063, a potent p38 MAPK inhibitor, alleviates acute lung injury induced by intestinal ischemia reperfusion in rats associated with AQP4 downregulation.
Topics: Acute Lung Injury; Animals; Aquaporin 4; Disease Models, Animal; Humans; Imidazoles; Intestines; Lun | 2016 |